Summary:
ICON Development Solutions is conducting a research study in type 2 diabetic men and women, taking Metformin, ages 30-65.
This study will help researchers compare tests to measure how the body controls blood sugar levels and may help standardize how these tests are conducted for people with type 2 diabetes. The study will include IV (intravenous) infusions.
Vital signs, ECGs, and physical examinations will be performed, and blood and urine samples will be obtained during this study. Meal tolerance tests will also be performed.
Qualified Participants Must:
• Be male or female between the ages of 30 and 65
•
Have a current diagnosis of type II diabetes and taking Metformin only to control diabetes
•
Have a BMI between 27 and 40 kg/m2
•
Have maintained a stable weight for 3 months prior to start of the study
•
If female, be willing to use a non-hormonal method of contraception to avoid pregnancy for the duration of the study
•
Not have participated in a research study in the past 30 days prior to screening
•
Complete up to 1 screening visit and 5 overnights (2 periods of 2 nights each and one period of 1 night)
Qualified Participants May Receive:
All study-related exams at no cost and compensation up to $2000.00 for time and travel.